Greetings from MyCancerHaven!

We wanted to update you on our recent activities.
‍
We've added below videos to our Videos repository.

‍The video is titled

Daratumumab SC + VRD For Transplant-ineligible or Transplant-deferred Newly Diagnosed Multiple Myeloma: The Phase 3 CEPHEUS Study by Saad Z. Usmani from Chief of Myeloma Service, Memorial Sloan Kettering Cancer Center  New York, NY , and it's been added/updated in Multiple Myeloma Category

Here are the latest posts last week:

‍Blogs :

Incorporation of GPRC5D-Targeted Therapies in the Treatment of Relapsed/Refractory Multiple Myeloma

Addressing reluctance and barriers in patient referrals to academic care.

Dr. Krishnan on Optimizing the Use of DKd in Relapsed/Refractory Multiple Myeloma.

Dr. Lentzsch Discusses the Safety of Linvoseltamab in Relapsed/Refractory Multiple Myeloma Dr. Banerjee on Future Prospects for Bispecific Antibody Therapy in Myeloma

Collaborative Care vs. Independent Treatment: How Does It Affect Patient Outcomes in MM

Incorporating GPRC5D-Targeted Therapies into Treatment for Relapsed/Refractory Multiple Myeloma

‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.